Characterization of newly established human myeloid leukemia cell line (KF-19) and its drug resistant sublines

Leukemia Research

Volumn 20, Issue 11-12, 1996, Pages 931-939

  Fukuda, Takeaki ^a,b   Kamishima, Tomoko ^a   Kakihara, Toshio ^a   Ohnishi, Yoshihisa ^a   Suzuki, Toshimitsu ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

AraC; Atypical cross resistance; Drug resistance; KF 19

Indexed keywords

CYCLOSPORIN A; CYTARABINE; DEOXYCYTIDINE KINASE; DOXORUBICIN; GLYCOPROTEIN P; VERAPAMIL; VINCRISTINE;

ARTICLE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MYELOID LEUKEMIA; PERICARDIAL EFFUSION; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC AGENTS; CYCLOSPORINE; CYTARABINE; DEOXYCYTIDINE KINASE; DNA TOPOISOMERASES, TYPE II; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; GLUTATHIONE TRANSFERASE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; METHOTREXATE; NEOPLASM PROTEINS; NUCLEOSIDE DEAMINASES; P-GLYCOPROTEIN; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; VERAPAMIL;

EID: 0030294912     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00063-X     Document Type: Article

References (29)

1. 1. Beck W. T. (1987) The cell biology of multiple drug resistance. Biochem. Pharmacol. 36, 2879.
2. 2. Bradley G., Juranka P. F. & Ling V. (1988) Mechanism of multidrug resistance. Biochem. Biophys. Acta 948, 87.
3. 3. Goldstein S. P. C., Galski H., Fojo A., Willingham M., Lai S. L., Gazdar A., Pirker R., Green A., Crist A. & Brodeur G. M. (1989) Expression of multidrug resistance gene in human cancers. J. Natl Cancer. Inst 81, 116.
4. 4. Ling V. (1992) P-glycoprotein and resistance to anticancer drugs. Cancer 69, 2603.
5. 5. Beck W. T., Cirtain M. C., Danks M. K., Felsted R. L., Safa A. R., Wolverton J. S., Suttle D. P. & Trent J. M. (1987) Pharmacological, molecular, and cytogenetic analysis of atypical multidrug resistant human leukemic cells. Cancer Res. 47, 5455.
6. 6. Mirski S. E., Gerlach J. H. & Cole S. P. C. (1987) Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. Cancer Res. 47, 2594.
7. 7. Barrand A. M., Heppell-Parton C. A., Wright A. K., Rabbitts H. P. & Twentyman R. R. (1994) A 190 kilodalton protein overexpressed in non-P-glycoprotein containing multidrug-resistant cells and its relation to the MRP gene. J. Natl Cancer Inst. 86, 110.
8. 8. Cole S. P. C., Bhardwaj G., Gerfach J. H., Mackie J. E., Grant C. E., Almiquist K. C., Stewart A. J., Kurz E. U., Duncan A. M. V. & Deeley R. G. (1992) Over-expression of a transporter gene in multidrug-resistant human lung cancer cell line. Science 258, 1650.
9. 9. Arceci R. J. (1993) Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood 81, 2215.
10. 10. Nooter K. & Sonneveld R. (1994) Clinical relevance of P-glycoprotein expression in hematological malignancies. Leukemia Res. 18, 233.
11. 11. Kakihara T., Yamada T., Fukuda T., Ohnishi Y., Kishi K. & Shibata A. (1991) Vincristine resistant human leukemic cell line; new monoclonal antibodies to a 65 kDa membrane protein. Leuk. Lymphoma 7, 157.
12. 12. Kakihara T., Yamada T., Fukuda T., Ohnishi Y., Kishi K., Uchiyama M. & Shibata A. (1993) Induction of surface antigen recognized by new monoclonal antibody, YU-311, on 1-β-D-arabinofuranosylcytosine-resistant human leukemic cell line. Leukemia Res. 17, 541.
13. 13. Fukuda T., Kakihara T., Kamishima T., Ohnishi Y., Naito M., Kishi K., Shibata A. & Tsuruo T. (1994) Characterization of newly established adriamycin resistant human leukemic cell lines (KY-ADR1 and KY-ADR2). Leukemia Res. 18, 709.
14. 14. Kakihara T. (1991) The characterization of highly resistant human leukemic cell lines to 1-β-D-arabinofuranosylcytosine. Acta Med. Biol. 39, 119.
15. 15. Habig W. H., Pabst M. J. & Jakoby W. B. (1974) Glutathione-S-transferase; the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249, 7130.
16. 16. Momparler R. L, Fischer G. A. (1968) Mammalian deoxynucleoside kinases. I. Deoxycytidine kinase: purification properties and kinetic studies with cytosine arabinoside. J. Biol. Chem. 243, 4298.
17. 17. Stewart C. D. & Burke P. J. (1971) Cytidine deaminase and the development of resistance to arabinosyl cytosine. Natl New Biol. 233, 109.
18. 18. Fukuda T., Kakihara T., Kamishima T., Naito M., Kishi K. & Shibata A. (1992) Different effects of various hematopoietic growth factors on myelomonocytic cell line (KY-821) and its drug resistant sublines. Leukemia Res. 17, 325.
19. 19. Leyland-Jones B., Dalton W., Fisher G. A. & Sikic B. I. (1993) Reversal of multidrug resistance to cancer chemotherapy. Cancer 72, 3484.
20. 20. Hasegawa S., Abe T., Naito S., Kotoh S., Kumazawa J., Hipfer D. R., Deeley R. G., Cole S. P. C. & Kuwano M. (1995) Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines. Br. J. Cancer 71, 907.
21. 21. Hamada H., Okochi E., Watanabe M., Ohhara T., Sugimoto Y., Kawabata H. & Tsuruo T. (1989) Mr 85000 membrane protein specifically expressed in adriamycin-resistant human tumor cells. Cancer Res. 48, 7082.
22. 22. Danks M. K., Metzger D. W., Ashmun R. A. & Beck W. T. (1985) Monoclonal antibodies to glycoproteins of vincaalkaloid resistant human leukemic cells. Cancer Res. 45, 3220.
23. 23. Wiley J. S., Jones S. P., Sawyer W. H. & Paterson A. R. P. (1982) Cytosine arabinoside influx and nucleoside transport sites in acute leukemia. J. Clin. Invest. 69, 479.
24. 24. Rustum Y. M. & Preisler H. D. (1979) Correlation between leukemic cell retention of 1-β-D-arabinofuranosylcytosine 5-triphosphate and response to therapy. Cancer Res. 39, 42.
25. 25. Kufe D. W., Major P. P., Egan E. M. & Beardsley G. R. (1980) Correlation of cytotoxicity with incorporation of ara-C into DNA. J. Biol. Chem. 255, 8997.
26. 26. Leclerc J. M. & Cheng Y. C. (1984) Demonstration of activities in leukemic cells capable of removing 1-β-D-arabinofuranosyl cytosine (ara-C) from ara-C incorporated DNA. Proc. Am. Assoc. Cancer. Res. 25, 19.
27. 27. Tanaka M. & Yoshida S. (1982) Altered sensitivity to 1-β-D-arabinofuranosylcytosine 5′-triphosphate to DNA polymerase from leukemia blasts of acute lymphoblastic leukemia. Cancer Res. 42, 649.
28. 28. Kolla S. S. & Studzinski G. R. (1994) Constitutive DNA binding of the low mobility forms of the AP-1 and SPA transcription factors in HL60 cells resistant to 1-β-D-arabinofuranosylcytosine. Cancer Res. 54, 1418.
29. 29. Kobayashi T., Kakihara T., Uchiyama M., Fukuda T., Kishi K. & Shibata A. (1994) Low expression of the deoxycytidine kinase (dCK) gene in a 1-β-D arabinofuranosylcytosine-resistant human leukemic cell line KY-Ra. Leuk. Lymphoma 15, 503.